Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term safety from the raltegravir clinical development program.
Teppler H, Brown DD, Leavitt RY, Sklar P, Wan H, Xu X, Lievano F, Lehman HP, Mast TC, Nguyen BY. Teppler H, et al. Among authors: brown dd. Curr HIV Res. 2011 Jan;9(1):40-53. doi: 10.2174/157016211794582650. Curr HIV Res. 2011. PMID: 21198432 Free PMC article.
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.
Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM, Brown SJ, Kulkarni P, Dubey SA, Kierstead LS, Casimiro DR, Mogg R, DiNubile MJ, Shiver JW, Leavitt RY, Robertson MN, Mehrotra DV, Quirk E; Merck V520-016 Study Group. Priddy FH, et al. Clin Infect Dis. 2008 Jun 1;46(11):1769-81. doi: 10.1086/587993. Clin Infect Dis. 2008. PMID: 18433307 Clinical Trial.
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial.
Vanhoutte F, Liu W, Wiedmann RT, Haspeslagh L, Cao X, Boundy K, Aliprantis A, Davila M, Hartzel J, Li J, McGuire M, Ramsauer K, Tomberger Y, Tschismarov R, Brown DD, Xu W, Sachs JR, Russell K, Stoch SA, Lai E. Vanhoutte F, et al. Among authors: brown dd. EBioMedicine. 2022 Jan;75:103811. doi: 10.1016/j.ebiom.2021.103811. Epub 2022 Jan 15. EBioMedicine. 2022. PMID: 35042081 Free PMC article. Clinical Trial.
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study.
Asselah T, Pol S, Hezode C, Loustaud-Ratti V, Leroy V, Ahmed SNS, Ozenne V, Bronowicki JP, Larrey D, Tran A, Alric L, Nguyen-Khac E, Robertson MN, Hanna GJ, Brown D, Asante-Appiah E, Su FH, Hwang P, Hall JD, Guidoum A, Hagen K, Haber BA, Talwani R, Serfaty L. Asselah T, et al. Liver Int. 2020 May;40(5):1042-1051. doi: 10.1111/liv.14313. Epub 2020 Mar 22. Liver Int. 2020. PMID: 31765046 Clinical Trial.
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence in cancer.
Panesso-Gómez S, Cole AJ, Wield A, Anyaeche VI, Shah J, Jiang Q, Ebai T, Sharrow AC, Tseng G, Yoon E, Brown DD, Clark AM, Larsen SD, Eder I, Gau D, Roy P, Dahl KN, Tran L, Jiang H, McAuliffe PF, Lee AV, Buckanovich RJ. Panesso-Gómez S, et al. Among authors: brown dd. bioRxiv [Preprint]. 2024 Nov 17:2024.11.15.623825. doi: 10.1101/2024.11.15.623825. bioRxiv. 2024. PMID: 39605642 Free PMC article. Preprint.
Hope for Others: Research Results from the University of Pittsburgh Rapid Autopsy Program for Breast Cancer.
Chang AC, Balic M, Bartholow T, Bhargava R, Brown DD, Brown L, Brufsky A, Cao Y, Carleton N, Clark AM, Cody M, Ding K, Deible C, Elangovan A, Foldi J, Geisler D, Hodgdon C, Howard N, Li Z, Liu JB, Lopez-Nunez O, Mary SJ, McGinn O, Miller L, Mori K, Pecar G, Priedigkeit N, Puhalla S, Rosenzweig MQ, Roy P, Savariau L, Walker S, Waltermire H, Wedn AM, Wells A, Yates ME, Xavier J, Lee AV, Oesterreich S. Chang AC, et al. Among authors: brown dd. bioRxiv [Preprint]. 2024 Nov 8:2024.11.06.621982. doi: 10.1101/2024.11.06.621982. bioRxiv. 2024. PMID: 39574596 Free PMC article. Preprint.
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women.
Carleton N, Lee S, Li R, Zou J, Brown DD, Hooda J, Chang A, Kumar R, Klei LR, Rigatti LH, Newsome J, John Mary DJS, Atkinson JM, West RE, Nolin TD, Oberly PJ, Huang Z, Poirier D, Diego EJ, Lucas PC, Tseng G, Lotze MT, McAuliffe PF, Zervantonakis IK, Oesterreich S, Lee AV. Carleton N, et al. Among authors: brown dd. bioRxiv [Preprint]. 2024 Oct 21:2024.10.18.616978. doi: 10.1101/2024.10.18.616978. bioRxiv. 2024. PMID: 39484485 Free PMC article. Preprint.
378 results